Effects of Uyghur medicine Abnormal Savda Munziq Powder on the pulmonary mucin secretion of COPD rats with abnormal savda syndrome

Zhen GAO,Min JIANG,Jing WANG,Dan XU,Jing JING,Zheng LI,Feng-sen LI
2017-01-01
Abstract:Objective:To study the effects of Uyghur medicine Abnormal Savda Munziq (ASM) Powder on the secretion of pulmonary mucin (MUC5AC,MUC5B) of chronic obstructive pulmonary disease (COPD) rats with abnormal savda syndrome.Methods:The COPD model was established by tracheal dripping porcine pancreatic elastase (PPE) combined with 90-day smoking.The chronic obstructive pulmonary disease with abnormal savda syndrome (ASSCOPD) model was established by cold food diet,cold-dryness environment and electric foot shocks on the basis of COPD model.Then,the rats were randomly divided into the ASSCOPD group and the ASMCOPD group,and the ASMCOPD group was gavaged the 0.54g ·200g1 ·d1 of ASM Powder for 7 days.The proteins expression of MUC5AC and MUC5B in the lung were detected by western bolt and analyzed by SPSS 11.5 software.Results:Compared with the control group,MUC5AC level in the COPD and ASSCOPD group was increased (P<0.01,P<0.05) and MUC5AC level in the ASMCOPD group was decreased (P<0.01).Compared with the ASSCOPD group,MUC5AC level in the ASMCOPD group was decreased (P<0.01) and MUC5B level was increased (P<0.05).Conclusion:ASM could reduce the high protein expression of MUC5AC in COPD rats with abnormal savda syndrome,and increase the protein expression of MUC5B,which could be one of the mechanisms of ASM Powder in treating COPD.
What problem does this paper attempt to address?